Branchiootorenal Syndrome and Oculoauriculovertebral Spectrum

Total Page:16

File Type:pdf, Size:1020Kb

Branchiootorenal Syndrome and Oculoauriculovertebral Spectrum ß 2008 Wiley-Liss, Inc. American Journal of Medical Genetics Part A 146A:2480–2489 (2008) Branchiootorenal Syndrome and Oculoauriculovertebral Spectrum Features Associated With Duplication of SIX1, SIX6, and OTX2 Resulting From a Complex Chromosomal Rearrangement Zhishuo Ou,1 Donna M. Martin,2,3 Jirair K. Bedoyan,2 M. Lance Cooper,1 A. Craig Chinault,1 Pawel Stankiewicz,1 and Sau W. Cheung1* 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 2Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan 3Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan Received 21 December 2007; Accepted 29 April 2008 We report on a 26-month-old boy with developmental delay 13q21.31–q21.32 in both the propositus and his father and and multiple congenital anomalies, including many features FISH supported the apparent association of the two events. suggestive of either branchiootorenal syndrome (BOR) or Chromosome 14q22.3–q23.3 contains 51 genes, including oculoauriculovertebral spectrum (OAVS). Chromosomal SIX1, SIX6, and OTX2. A locus for branchiootic syndrome microarray analysis (CMA) initially revealed a copy-number (BOS) has been mapped to 14q21.3–q24.3, and designated gain with a single BAC clone (RP11-79M1) mapping to as branchiootic syndrome 3 (BOS3). Interestingly, mutations 14q23.1. FISH analysis showed that the third copy of this in SIX1 have been reported in patients with BOR/BOS3. We genomic region was inserted into the long arm of one propose that the increased dosage of SIX1, SIX6,orOTX2 chromosome 13. The same pattern was also seen in the may be responsible for the BOR and OAVS-like features in chromosomes of the father, who has mental retardation, this family. ß 2008 Wiley-Liss, Inc. short stature, hypernasal speech, and minor craniofacial anomalies, including tall forehead, and crowded dentition. Subsequent whole genome oligonucleotide microarray Key words: SIX1; SIX6; OTX2; branchiootorenal syn- analysis revealed an 11.79 Mb duplication of chromosome drome; oculoauriculovertebral spectrum; segmental trisomy; 14q22.3–q23.3 and a loss of an 4.38 Mb sequence in insertional translocation How to cite this article: Ou Z, Martin DM, Bedoyan JK, Cooper ML, Chinault AC, Stankiewicz P, Cheung SW. 2008. Branchiootorenal syndrome and oculoauriculovertebral spectrum features associated with duplication of SIX1, SIX6, and OTX2 resulting from a complex chromosomal rearrangement. Am J Med Genet Part A 146A:2480–2489. INTRODUCTION anomalies, middle ear anomalies, inner ear anoma- lies, preauricular tags, facial asymmetry, and palate Branchiootorenal syndrome (BOR; OMIM 113650) abnormalities, or (3) one major criterion and an is an autosomal dominant disorder caused by affected first-degree relative who meets the criteria mutations in the EYA1 gene (OMIM 601653) [Abdel- for BOR syndrome [Chang et al., 2004]. Branchiootic hak et al., 1997], a human homolog of the Drosophila syndrome (BOS; OMIM 602588), a related disorder eyes absent gene (Eya) [Bonini et al., 1993]. BOR is but without the renal anomalies, can also be caused characterized by hearing loss, branchial cleft fistulas by allelic defects in EYA1 [Vincent et al., 1997]. or cysts, ear pits, renal dysplasia, and otologic A second locus for BOS was localized to chromo- manifestations ranging from mild hypoplasia to complete absence with reduced penetrance and variable expressivity [Melnick et al., 1975; Fraser *Correspondence to: Dr. Sau W. Cheung, Ph.D, M.B.A, Department of et al., 1978]. Clinical diagnosis of BOR is based on the Molecular and Human Genetics, Baylor College of Medicine, John P. presence of (1) at least three major criteria including McGovern Campus, Rm. NABS-270, Houston, TX 77030. branchial anomalies, deafness, preauricular pits, and E-mail: [email protected] Published online 29 July 2008 in Wiley InterScience renal abnormalities, (2) two major criteria, and at (www.interscience.wiley.com) least two minor criteria including external ear DOI 10.1002/ajmg.a.32398 American Journal of Medical Genetics Part A SIX1 DUPLICATION ASSOCIATED WITH BOR AND OAVS 2481 some 1q31 (OMIM 120502) [Kumar et al., 2000]. and two other paternal relatives have the same Recently, Ruf et al. [2003] mapped a third gene locus unbalanced aberration and learning disability, sig- for BOR/BOS to 14q21.3–q24.3 by linkage study and nificant developmental delays, and subtle dysmor- designated it as branchiootic syndrome 3 (BOS3; phic features. We propose that increased dosage of OMIM 608389). This chromosomal region contains SIX1, SIX6,orOTX2 may be responsible for BOR- the SIX1, SIX4, SIX6 (OMIM 601205, OMIM 606342, and OAVS-like phenotypes in this family. OMIM 606326, respectively) gene cluster, the prod- ucts of which are known to act in a developmental CLINICAL REPORT pathway of the EYA genes [Xu et al., 1999], and OTX2 (OMIM 600037). Mutations in SIX1 have been The propositus (Fig. 1A–C) is a 26-month-old male reported in patients with BOR/BOS, thus identifying born to a primiparous 21-year-old woman at SIX1 as a gene causing BOR and BOS [Ruf et al., 39 weeks by cesarean section. Ultrasound studies at 2004]. 21 weeks gestation suggested an occipital encepha- Oculoauriculovertebral spectrum (OAVS; OMIM locele or meningocele. Amniocentesis performed at 164210) is a common birth defect pattern (1 in 5,600 11 weeks showed a normal male karyotype. His birth live births) involving first and second branchial arch weight was 1,997 g (1st centile) and head circum- derivatives [Gorlin et al., 1990, 2001]. The phenotype ference was 31 cm (2nd centile). Initial evaluation of OAVS is extremely variable, with no generally at 6 weeks of age indicated a weight of 3.04 kg accepted minimal diagnostic criteria [Regenbogen (<3rd centile), length of 48.1 cm (<3rd centile) and et al., 1982; Kaye et al., 1992]. The disorder includes head circumference of 34.7 cm (1st centile). At the Goldenhar syndrome, which is defined as the 8 months weight was 5.49 kg (<3rd centile), length combination of microtia, hemifacial microsomia, 61.7 cm (<3rd centile) and head circumference dermoids, and vertebral anomalies. The features of 41.1 cm (<3rd centile); he could smile and babble, OAVS include unilateral malformation of the external reach for objects, and transfer objects from hand to ear and asymmetric facial hypoplasia with epibulbar hand. He was turning to voices, but was not yet dermoid and vertebral anomalies. Coloboma of the sitting. Re-evaluation at 26 months showed persistent upper eyelid is frequent. The ear defects include growth delays and microcephaly, with weight preauricular tags of cartilagenous masses, atresia of 7.65 kg (<3rd centile), length 76.3 cm (<3rd centile) the external auditory canal, anomalies in the size and and head circumference 43.5 cm (<3rd centile). He shape of the external auricle, and anotia [Gorlin et al., was walking with some assistance and using several 2001]. Cardiac, vertebral, and central nervous system single words to communicate. defects have also been described [Rollnick et al., Physical findings first noted in the newborn period 1987]. The etiology of OAVS is unclear; autosomal included large fontanels and a tall prominent fore- dominant, autosomal recessive and multifactorial head. The right occiput appeared more prominent inheritance have been described [Rollnick and Kaye, than the left occiput. Torticollis to the left was noted. 1983; Kelberman et al., 2001]. Chromosomal abnor- He had a recessed jaw with a highly arched palate malities described in patients with OAVS include and possible short tongue. He had multiple skin trisomies 18 [Verloes et al., 1991] and 22 [Kobrynski tags in the preauricular and cheek regions as well as et al., 1993], mosaic trisomies 9 [Wilson and Barr, pits on the right cheek. Other dysmorphic features 1983] and 17 [Hodes et al., 1981], duplication of 8pter included short nose with broad nasal bridge, short [Josifova et al., 2004], deletions of 5p14 to 5pter palpebral fissures with copious tearing suggesting [Choong et al., 2003] and 22qter [Herman et al., 1988], lacrimal duct stenosis (he underwent subsequent pericentric inversions of chromosome 1 with break- lacrimal duct stent placement bilaterally), low set points at p13 and q21 [Stahl-Mauge´ et al., 1982] and ears with abnormal antihelix and ear lobe, prom- chromosome 9 with breakpoints at p11 and q13 inence of the maxilla, severe hypoplasia of the [Stanojevic´ et al., 2000], and the recurrent unbalanced mandible with broadening of the oral region, and translocation der(11)t(11;22)(q23;q112) [Balci et al., macrostomia with bilateral Tessier number 7 clefts 2006]. Furthermore, data from a family with features (with subsequent surgical reconstruction at 8 months of hemifacial microsomia suggest linkage to a region of age) and micrognathia. His neck appeared short of approximately 10.7 cM on chromosome 14q32 and abnormally shaped but with no webbing. [Kelberman et al., 2001]. Cranial ultrasound showed normal sulcal pattern We describe a patient with features of BOR and with no ventriculomegaly. MRI of the brain on day of OAVS in whom a chromosome segment from life 4 showed no evidence of hydrocephalus or Chiari 14q22.3–q23.3 is duplicated and directly inserted malformation. A 5 cm meningocele was noted with into chromosome 13q21, resulting in a 11.79 Mb fibrous band tissue and dura but no brain paren- trisomy of chromosome 14q22.3–23.3 that includes chyma. Corpus callosum was thin. SIX1, SIX6, OTX2, and an associated deletion of an Because of a deep sacral dimple, neonatal ultra- 4.38 Mb gene-poor region on chromosome sound of the spinal cord was performed and showed 13q21.31–q21.32. Interestingly, the patient’s father conus tip slightly low at L4 with normal filum American Journal of Medical Genetics Part A 2482 OU ET AL. FIG.1. Photographs of the propositus 26 months (A–C) and his father (D–F).
Recommended publications
  • Transcriptional Profile Analysis of RPGRORF15 Frameshift Mutation Identifies Novel Genes Associated with Retinal Degeneration
    Retinal Cell Biology Transcriptional Profile Analysis of RPGRORF15 Frameshift Mutation Identifies Novel Genes Associated with Retinal Degeneration Sem Genini,1 Barbara Zangerl,1 Julianna Slavik,1 Gregory M. Acland,2 William A. Beltran,1 and Gustavo D. Aguirre1 PURPOSE. To identify genes and molecular mechanisms associ- he term retinitis pigmentosa (RP) refers to a group of many ated with photoreceptor degeneration in a canine model of Tdifferent inherited retinal diseases characterized by pro- XLRP caused by an RPGR exon ORF15 microdeletion. gressive rod or rod–cone photoreceptor degeneration that causes subsequent visual impairment and blindness. Some of METHODS. Expression profiles of mutant and normal retinas were compared by using canine retinal custom cDNA microar- the causative genes have clear, well-identified roles (e.g., in- volvement in phototransduction, in maintaining photoreceptor rays. qRT-PCR, Western blot analysis, and immunohistochem- structure, or in RPE retinoid metabolism; RetNet: http://www. istry (IHC) were applied to selected genes, to confirm and sph.uth.tmc.edu/RetNet/ provided in the public domain by the expand the microarray results. University of Texas Houston Health Science Center, Houston, RESULTS. At 7 and 16 weeks, respectively, 56 and 18 tran- TX). However, there remain a large number of diseases caused scripts were downregulated in the mutant retinas, but none by genes with poorly understood functions and for which the were differentially expressed (DE) at both ages, suggesting mechanism linking the genes and/or mutations with photore- the involvement of temporally distinct pathways. Down- ceptor disease and degeneration is unknown. regulated genes included the known retina-relevant genes Among these is the RP3 form of X-linked RP (XLRP), a PAX6, CHML, and RDH11 at 7 weeks and CRX and SAG at uniformly severe, early-onset retinal disease in humans that is 16 weeks.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
    Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database.
    [Show full text]
  • NICU Gene List Generator.Xlsx
    Neonatal Crisis Sequencing Panel Gene List Genes: A2ML1 - B3GLCT A2ML1 ADAMTS9 ALG1 ARHGEF15 AAAS ADAMTSL2 ALG11 ARHGEF9 AARS1 ADAR ALG12 ARID1A AARS2 ADARB1 ALG13 ARID1B ABAT ADCY6 ALG14 ARID2 ABCA12 ADD3 ALG2 ARL13B ABCA3 ADGRG1 ALG3 ARL6 ABCA4 ADGRV1 ALG6 ARMC9 ABCB11 ADK ALG8 ARPC1B ABCB4 ADNP ALG9 ARSA ABCC6 ADPRS ALK ARSL ABCC8 ADSL ALMS1 ARX ABCC9 AEBP1 ALOX12B ASAH1 ABCD1 AFF3 ALOXE3 ASCC1 ABCD3 AFF4 ALPK3 ASH1L ABCD4 AFG3L2 ALPL ASL ABHD5 AGA ALS2 ASNS ACAD8 AGK ALX3 ASPA ACAD9 AGL ALX4 ASPM ACADM AGPS AMELX ASS1 ACADS AGRN AMER1 ASXL1 ACADSB AGT AMH ASXL3 ACADVL AGTPBP1 AMHR2 ATAD1 ACAN AGTR1 AMN ATL1 ACAT1 AGXT AMPD2 ATM ACE AHCY AMT ATP1A1 ACO2 AHDC1 ANK1 ATP1A2 ACOX1 AHI1 ANK2 ATP1A3 ACP5 AIFM1 ANKH ATP2A1 ACSF3 AIMP1 ANKLE2 ATP5F1A ACTA1 AIMP2 ANKRD11 ATP5F1D ACTA2 AIRE ANKRD26 ATP5F1E ACTB AKAP9 ANTXR2 ATP6V0A2 ACTC1 AKR1D1 AP1S2 ATP6V1B1 ACTG1 AKT2 AP2S1 ATP7A ACTG2 AKT3 AP3B1 ATP8A2 ACTL6B ALAS2 AP3B2 ATP8B1 ACTN1 ALB AP4B1 ATPAF2 ACTN2 ALDH18A1 AP4M1 ATR ACTN4 ALDH1A3 AP4S1 ATRX ACVR1 ALDH3A2 APC AUH ACVRL1 ALDH4A1 APTX AVPR2 ACY1 ALDH5A1 AR B3GALNT2 ADA ALDH6A1 ARFGEF2 B3GALT6 ADAMTS13 ALDH7A1 ARG1 B3GAT3 ADAMTS2 ALDOB ARHGAP31 B3GLCT Updated: 03/15/2021; v.3.6 1 Neonatal Crisis Sequencing Panel Gene List Genes: B4GALT1 - COL11A2 B4GALT1 C1QBP CD3G CHKB B4GALT7 C3 CD40LG CHMP1A B4GAT1 CA2 CD59 CHRNA1 B9D1 CA5A CD70 CHRNB1 B9D2 CACNA1A CD96 CHRND BAAT CACNA1C CDAN1 CHRNE BBIP1 CACNA1D CDC42 CHRNG BBS1 CACNA1E CDH1 CHST14 BBS10 CACNA1F CDH2 CHST3 BBS12 CACNA1G CDK10 CHUK BBS2 CACNA2D2 CDK13 CILK1 BBS4 CACNB2 CDK5RAP2
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • SUPPLEMENTARY MATERIAL Bone Morphogenetic Protein 4 Promotes
    www.intjdevbiol.com doi: 10.1387/ijdb.160040mk SUPPLEMENTARY MATERIAL corresponding to: Bone morphogenetic protein 4 promotes craniofacial neural crest induction from human pluripotent stem cells SUMIYO MIMURA, MIKA SUGA, KAORI OKADA, MASAKI KINEHARA, HIROKI NIKAWA and MIHO K. FURUE* *Address correspondence to: Miho Kusuda Furue. Laboratory of Stem Cell Cultures, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8, Saito-Asagi, Ibaraki, Osaka 567-0085, Japan. Tel: 81-72-641-9819. Fax: 81-72-641-9812. E-mail: [email protected] Full text for this paper is available at: http://dx.doi.org/10.1387/ijdb.160040mk TABLE S1 PRIMER LIST FOR QRT-PCR Gene forward reverse AP2α AATTTCTCAACCGACAACATT ATCTGTTTTGTAGCCAGGAGC CDX2 CTGGAGCTGGAGAAGGAGTTTC ATTTTAACCTGCCTCTCAGAGAGC DLX1 AGTTTGCAGTTGCAGGCTTT CCCTGCTTCATCAGCTTCTT FOXD3 CAGCGGTTCGGCGGGAGG TGAGTGAGAGGTTGTGGCGGATG GAPDH CAAAGTTGTCATGGATGACC CCATGGAGAAGGCTGGGG MSX1 GGATCAGACTTCGGAGAGTGAACT GCCTTCCCTTTAACCCTCACA NANOG TGAACCTCAGCTACAAACAG TGGTGGTAGGAAGAGTAAAG OCT4 GACAGGGGGAGGGGAGGAGCTAGG CTTCCCTCCAACCAGTTGCCCCAAA PAX3 TTGCAATGGCCTCTCAC AGGGGAGAGCGCGTAATC PAX6 GTCCATCTTTGCTTGGGAAA TAGCCAGGTTGCGAAGAACT p75 TCATCCCTGTCTATTGCTCCA TGTTCTGCTTGCAGCTGTTC SOX9 AATGGAGCAGCGAAATCAAC CAGAGAGATTTAGCACACTGATC SOX10 GACCAGTACCCGCACCTG CGCTTGTCACTTTCGTTCAG Suppl. Fig. S1. Comparison of the gene expression profiles of the ES cells and the cells induced by NC and NC-B condition. Scatter plots compares the normalized expression of every gene on the array (refer to Table S3). The central line
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Confirmation of Pathogenic Mechanisms by SARS-Cov-2–Host
    Messina et al. Cell Death and Disease (2021) 12:788 https://doi.org/10.1038/s41419-021-03881-8 Cell Death & Disease ARTICLE Open Access Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome Francesco Messina 1, Emanuela Giombini1, Chiara Montaldo1, Ashish Arunkumar Sharma2, Antonio Zoccoli3, Rafick-Pierre Sekaly2, Franco Locatelli4, Alimuddin Zumla5, Markus Maeurer6,7, Maria R. Capobianchi1, Francesco Nicola Lauria1 and Giuseppe Ippolito 1 Abstract In the last months, many studies have clearly described several mechanisms of SARS-CoV-2 infection at cell and tissue level, but the mechanisms of interaction between host and SARS-CoV-2, determining the grade of COVID-19 severity, are still unknown. We provide a network analysis on protein–protein interactions (PPI) between viral and host proteins to better identify host biological responses, induced by both whole proteome of SARS-CoV-2 and specific viral proteins. A host-virus interactome was inferred, applying an explorative algorithm (Random Walk with Restart, RWR) triggered by 28 proteins of SARS-CoV-2. The analysis of PPI allowed to estimate the distribution of SARS-CoV-2 proteins in the host cell. Interactome built around one single viral protein allowed to define a different response, underlining as ORF8 and ORF3a modulated cardiovascular diseases and pro-inflammatory pathways, respectively. Finally, the network-based approach highlighted a possible direct action of ORF3a and NS7b to enhancing Bradykinin Storm. This network-based representation of SARS-CoV-2 infection could be a framework for pathogenic evaluation of specific 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; clinical outcomes.
    [Show full text]
  • High Mutation Frequency of the PIGA Gene in T Cells Results In
    High Mutation Frequency of the PIGA Gene in T Cells Results in Reconstitution of GPI A nchor−/CD52− T Cells That Can Give Early Immune Protection after This information is current as Alemtuzumab-Based T Cell−Depleted of October 1, 2021. Allogeneic Stem Cell Transplantation Floris C. Loeff, J. H. Frederik Falkenburg, Lois Hageman, Wesley Huisman, Sabrina A. J. Veld, H. M. Esther van Egmond, Marian van de Meent, Peter A. von dem Borne, Hendrik Veelken, Constantijn J. M. Halkes and Inge Jedema Downloaded from J Immunol published online 2 February 2018 http://www.jimmunol.org/content/early/2018/02/02/jimmun ol.1701018 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2018/02/02/jimmunol.170101 Material 8.DCSupplemental Why The JI? Submit online. by guest on October 1, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published February 2, 2018, doi:10.4049/jimmunol.1701018 The Journal of Immunology High Mutation Frequency of the PIGA Gene in T Cells Results in Reconstitution of GPI Anchor2/CD522 T Cells That Can Give Early Immune Protection after Alemtuzumab- Based T Cell–Depleted Allogeneic Stem Cell Transplantation Floris C.
    [Show full text]
  • Viewed and Published Immediately Upon Acceptance Cited in Pubmed and Archived on Pubmed Central Yours — You Keep the Copyright
    BMC Genomics BioMed Central Research article Open Access Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice Claudia Prinzen1, Dietrich Trümbach2, Wolfgang Wurst2, Kristina Endres1, Rolf Postina1 and Falk Fahrenholz*1 Address: 1Johannes Gutenberg-University, Institute of Biochemistry, Mainz, Johann-Joachim-Becherweg 30, 55128 Mainz, Germany and 2Helmholtz Zentrum München – German Research Center for Environmental Health, Institute for Developmental Genetics, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany Email: Claudia Prinzen - [email protected]; Dietrich Trümbach - [email protected]; Wolfgang Wurst - [email protected]; Kristina Endres - [email protected]; Rolf Postina - [email protected]; Falk Fahrenholz* - [email protected] * Corresponding author Published: 5 February 2009 Received: 19 June 2008 Accepted: 5 February 2009 BMC Genomics 2009, 10:66 doi:10.1186/1471-2164-10-66 This article is available from: http://www.biomedcentral.com/1471-2164/10/66 © 2009 Prinzen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: In a transgenic mouse model of Alzheimer disease (AD), cleavage of the amyloid precursor protein (APP) by the α-secretase ADAM10 prevented amyloid plaque formation, and alleviated cognitive deficits. Furthermore, ADAM10 overexpression increased the cortical synaptogenesis. These results suggest that upregulation of ADAM10 in the brain has beneficial effects on AD pathology. Results: To assess the influence of ADAM10 on the gene expression profile in the brain, we performed a microarray analysis using RNA isolated from brains of five months old mice overexpressing either the α-secretase ADAM10, or a dominant-negative mutant (dn) of this enzyme.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]